Cardiology


Cardiology

Selected articles and automatically-renewing searches on various subtopics within geriatric cardiology
Atrial Fibrillation
Cardiovascular Disease 
Heart Failure
Hyperlipidemia
Hypertension
Peripheral Arterial Disease
Valvular Heart Disease

Atrial Fibrillation

Cheng EM, Fung CH. Quality indicators for the care of stroke and atrial fibrillation in vulnerable elders. J Am Geriatr Soc. 2007;55 Suppl 2:S431-7. 

Connolly SJ, Camm AJ, Halperin JL, et al; PALLAS Investigators. Dronedarone in high-risk permanent atrial fibrillation. N Engl J Med. 2011 Dec 15;365(24):2268-76.  PubMed PMID: 22082198.
 
Fang MC, Chen J, Rich MW. Atrial fibrillation in the elderly. Am J Med. 2007;120(6):481-487. 

Fernando HC, Jaklitsch MT, Walsh GL. The Society of Thoracic Surgeons practice guideline on the prophylaxis and management of atrial fibrillation associated with general thoracic surgery: executive summary. Ann Thorac Surg. 2011 Sep;92(3):1144-52. . PubMed PMID: 21871327.
 

Kaw R, Hernandez AV, Masood I, Gillinov AM, Saliba W, Blackstone EH. Short and long-term mortality associated with new-onset atrial fibrillation after coronary artery bypass grafting: a systematic review and meta-analysis. J Thorac Cardiovasc Surg. 011May;141(5):1305-12. PubMed PMID: 21247589.

Rahimi K, Emberson J, McGale P, et al; PROSPER Executive. Effect of statins on atrial fibrillation: collaborative meta-analysis of published and unpublished evidence from randomised controlled trials. BMJ. 2011 Mar 16;342:d1250. doi: 10.1136/bmj.d1250. PubMed PMID: 21411487.

PubMed Alerts: Atrial Fibrillation (limits: Major Topic, humans, English, adults≥65 years)

top


Cardiovascular Disease

De Ruijter W, Westendorp RGJ, Assendelft WJJ, et al. Use of Framingham risk score and new biomarkers to predict cardiovascular mortality in older people: population-based observational cohort study. BMJ 2009;338:a3083 ; DOI: 10.1136/bmj.a3083. 

Watson K, Fung CH, Budoff M. Quality indicators for the care of ischemic heart disease in vulnerable elders. J Am Geriatr Soc. 2007;55 Suppl 2:S366-72.  
top


Heart Failure

Heidenreich PA, Fonarow GC. Quality indicators for the care of heart failure in vulnerable elders. J Am Geriatr Soc. 2007;55 Suppl 2:S340-6  

Malasky B. Heart Failure-Diagnosis. Elder Care: A Resource for Interprofessional Providers.June 2008 (updated June 2010).

Malasky B. Heart Failure-Treatment. Elder Care: A Resource for Interprofessional Providers.July2008 (updated June 2010). 

Thomas S, Rich MW. Epidemiology, pathophysiology, and prognosis of heart failure in the elderly. Clin Geriatr Med. 2007;23(1):1-10. 
top


Hyperlipidemia

Howe CH, Weiss BD. Hyperlipidemia in Older Adults: to Treat or Not to Treat? Elder Care: A Resource for Interprofessional Providers. May 2010.
 
Jacobson TA. Overcoming 'ageism' bias in the treatment of hypercholesterolaemia : A review of safety issues with statins in the elderly. Drug Saf. 2006;29(5):421-448. 
top

Hypertension

Beckett NS, Peters R, Fletcher AE, et al. Treatment of hypertension in patients 80 years of age or older. N Engl J Med. 2008;358(18):1887-1898.

Browne, RS. Systolic Hypertension in Elders. Elder Care: A Resource for Interprofessional Providers.June 2007 (updated June 2010). 

Min LC, Mehrotra R, Fung CH. Quality indicators for the care of hypertension in vulnerable elders. J Am Geriatr Soc. 2007;55 Suppl 2:S359-65. 

top


Peripheral Arterial Disease

Aboyans V, Lacroix P, Postil A, et al. Subclinical peripheral arterial disease and incompressible ankle arteries are both long-term prognostic factors in patients undergoing coronary artery bypass grafting. J Am Coll Cardiol. 2005;46(5):815-820.

Espinola-Klein C, Rupprecht HJ, Bickel C, et al. Different calculations of ankle-brachial index and their impact on cardiovascular risk prediction. Circulation. 2008;118(9):961-967.

Feringa HH, Bax JJ, van Waning VH, et al. The long-term prognostic value of the resting and postexercise ankle-brachial index. Arch Intern Med. 2006;166(5):529-535.

Jones WS, Clare R, Ellis SJ, et al. Effect of peripheral arterial disease on functional and clinical outcomes in patients with heart failure (from HF-ACTION). Am J Cardiol. 2011;108(3):380-384.

Kennedy M, Solomon C, Manolio TA, et al. Risk factors for declining ankle-brachial index in men and women 65 years or older: the Cardiovascular Health Study. Arch Intern Med. 2005;165(16):1896-1902.

McDermott MM, Ferrucci L, Liu K, et al. Women with peripheral arterial disease experience faster functional decline than men with peripheral arterial disease. J Am Coll Cardiol. 2011;57(6):707-714.

McDermott MM, Liu K, Ferrucci L, et al. Greater sedentary hours and slower walking speed outside the home predict faster declines in functioning and adverse calf muscle changes in peripheral arterial disease. J Am Coll Cardiol. 2011;57(23):2356-2364.

Menke A, Muntner P, Wildman RP, Dreisbach AW, Raggi P. Relation of borderline peripheral arterial disease to cardiovascular disease risk. Am J Cardiol. 2006;98(9):1226-1230.

Moat NE, Ludman P, de Belder MA,et al. Long-term outcomes after transcatheter aortic valve implantation in high-risk patients with severe aortic stenosis: the U.K. TAVI (United Kingdom Transcatheter Aortic Valve Implantation) Registry. J Am Coll Cardiol. 2011 Nov 8;58(20):2130-8.Epub 2011 Oct 20. PubMed PMID: 22019110.

Murphy TP, Cutlip DE, Regensteiner JG, et al. Supervised exercise versus primary stenting for claudication resulting from aortoiliac peripheral artery disease: six-month outcomes from the claudication: exercise versus endoluminal revascularization (CLEVER) study. Circulation. 2012;125(1):130-139.

Pande RL, Perlstein TS, Beckman JA, Creager MA. Secondary prevention and mortality in peripheral artery disease: National Health and Nutrition Examination Study, 1999 to 2004. Circulation. 2011;124(1):17-23.

Parameswaran GI, Brand K, Dolan J. Pulse oximetry as a potential screening tool for lower extremity arterial disease in asymptomatic patients with diabetes mellitus. Arch Intern Med. 2005;165(4):442-446.
 
Sanna G, Alesso D, Mediati M, et al. Prevalence of peripheral arterial disease in subjects with moderate cardiovascular risk: Italian results from the PANDORA study Data from PANDORA (Prevalence of peripheral Arterial disease in subjects with moderate CVD risk, with No overt vascular Diseases nor Diabetes mellitus). BMC cardiovascular disorders. 2011;11:59.

Shahin Y, Mazari F, Chetter I. Do angiotensin converting enzyme inhibitors improve walking distance in patients with symptomatic lower limb arterial disease? A systematic review and meta-analysis of randomised controlled trials. International journal of surgery (London, England). 2011;9(3):209-213.

Taylor-Piliae RE, Fair JM, Varady AN, et al. Ankle brachial index screening in asymptomatic older adults. Am Heart J. 2011;161(5):979-985.

Tendera M, Aboyans V, Bartelink ML, et al. ESC Guidelines on the diagnosis and treatment of peripheral artery diseases: Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries: the Task Force on the Diagnosis and Treatment of Peripheral Artery Diseases of the European Society of Cardiology (ESC). Eur Heart J. 2011;32(22):2851-2906
.
Zagura M, Serg M, Kampus P, et al. Aortic stiffness and vitamin D are independent markers of aortic calcification in patients with peripheral arterial disease and in healthy subjects. Eur J Vasc Endovasc Surg. 2011;42(5):689-695.

PubMed Alerts: "Peripheral Arterial Disease" (limits:  MeSH Major Topic, humans, English, adults≥65 years)
top

Valvular Heart Disease

2006 Writing Committee Members, Bonow RO, Carabello BA, et al. 2008 Focused Update Incorporated Into the ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease. Circulation. 2008;118(15):e523 -e661.
 
Bekeredjian R, Krumsdorf U, Chorianopoulos E, et al. Usefulness of percutaneous aortic valve implantation to improve quality of life in patients >80 years of age. Am. J. Cardiol. 2010;106(12):1777-1781.
 
Ben-Dor I, Pichard AD, Gonzalez MA, et al. Correlates and causes of death in patients with severe symptomatic aortic stenosis who are not eligible to participate in a clinical trial of transcatheter aortic valve implantation. Circulation. 2010;122(11 Suppl):S37-42.
 
Figulla L, Neumann A, Figulla HR, Kahlert P, Erbel R, Neumann T. Transcatheter aortic valve implantation: evidence on safety and efficacy compared with medical therapy. A systematic review of current literature. Clin Res Cardiol. 2011;100(4):265-276.
 
Georgiadou P, Kontodima P, Sbarouni E, et al. Long-term quality of life improvement after transcatheter aortic valve implantation. Am. Heart J. 2011;162(2):232-237.
 
Kefer J, Beauloye C, Astarci P, et al. Usefulness of B-type natriuretic peptide to predict outcome of patients treated by transcatheter aortic valve implantation. Am. J. Cardiol. 2010;106(12):1782-1786.
 
Langanay T, Flécher E, Fouquet O, et al. Aortic valve replacement in the elderly: the real life. Ann. Thorac. Surg. 2012;93(1):70-78.
Markar SR, Sadat U, Edmonds L, Nair SK. Mitral valve repair versus replacement in the elderly population. J. Heart  Valve Dis. 2011;20(3):265-271.

Nistri S, Faggiano P, Olivotto I et al. Hemodynamic Progression and Outcome of Asymptomatic Aortic Stenosis in Primary Care. Am J Cardiol. 2011 Dec 9. [Epub ahead of print] PubMed PMID: 22154322.

Parolari A, Tremoli E, Cavallotti L, et al. Do statins improve outcomes and delay the progression of non-rheumatic calcific aortic stenosis? Heart. 2011;97(7):523-529.
 
Sutaria N, Elder AT, Shaw TR. Mitral balloon valvotomy for the treatment of mitral stenosis in octogenarians. J Am Geriatr Soc. 2000;48(8):971-974.
 
PubMed Alerts: "Heart Valve Diseases" (limits:  MeSH Major Topic, humans, English, adults≥65 years)
top
  • 162 reads